The global Renal Replacement Therapy market is projected to reach USD XX billion by 2027 from an estimated USD XX billion in 2020, at a CAGR of XX% during the forecast period. A rise in the chronic kidney disease owing to the adoption of sedentary lifestyle, stress and rising aging population are some of the prominent factors which is driving the demand of renal replacement therapy. As per CDC, More than 1 in 7, that is 15% of US adults or 37 million people, are estimated to have Chronic Kidney disease (CKD). Also, As many as 9 in 10 adults with CKD do not know they have CKD and About 2 in 5 adults with severe CKD do not know they have CKD.
Moreover, the growing incidence of AKI/AKF is expected to increase the demand for CRRT. According to the International Society of Nephrology (INR), an estimated 13.3 million cases of AKI are registered annually worldwide. This is anticipated to boost the adoption of continuous renal replacement therapy at a rapid rate. With the rapid growth in the geriatric population globally, the prevalence of kidney-related diseases is expected to increase significantly. This, in turn, is expected to propel the growth of the CRRT market at a significant rate during the forecast period.
The COVID-19 pandemic has significantly affected the CRRT market. The surge in the number of COVID cases, along with the rise in its severity rate, is likely to create a potential increase in the incidence of kidney damage. This makes AKI the next emerging healthcare concern after respiratory tract infections among patients with COVID-19. As coronavirus disease 2019 increased in early 2020, it became evident that patients infected with severe acute respiratory syndrome coronavirus 2 were at increased risk of developing AKI. In large United States cohorts studied at the beginning of the pandemic, 28%-46% of those hospitalized with COVID-19 developed AKI, and rates were markedly higher among patients requiring admission/transfer to the intensive care unit (ICU; 61%-78%).
Some of the prominent players operating in the market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, NIKKISO CO., LTD., B. Braun Melsungen AG, Asahi Kasei Corporation, Toray Medical Co., Ltd. , Infomed SA, Medtronic plc, Nipro Corporation.
Insights Presented in the Report
"Amongst Product Type, Dialysates segment holds the major share."
Based on Product type the market has been classified into Disposable, Machine, Dialysates, Renal Replacement fluid. The Dialysates segment accounted for the largest share of the Renal Replacement Therapy market in 2020. This segment's large share can be attributed due to the significant rise in demand for CRRT in the treatment of hemodynamically unstable patients.
"Amongst Type, contract sterilization segment holds the major share."
Based on type, the Renal Replacement Therapy market has been segmented into contract Renal Replacement Therapy and sterilization validation services. The contract Renal Replacement Therapy segment accounted for the highest CAGR of the Renal Replacement Therapy market during the forecast period.
"Amongst Modality, off-site segment dominated the market during the forecast period."
Based on Modality, the Renal Replacement Therapy market has been segmented into SCUF, CVVH, CVVHD, CVVHDF. In 2020, the CVVHDF segment accounted for a largest share of the Renal Replacement Therapy market. The growing preference of CVVHDF modality among a nephrologist and critical care physician, and the advantages such as better clearance of medium-sized solutes as compared to hemodialysis, proper acid-base balance without additional intervention are acting as a growth catalyst for this segment.
"Amongst Mode of Patient, Adults segment dominated the market during the forecast period."
Based on Mode of Patients, the Renal Replacement Therapy market has been segmented into Adults, Paediatrics and Neonates. The adults segment grabbed XX% market share in 2020. The rapidly growing cases of adult acute renal disease injury across the globe and the rising number of hospital admission among youth adults are playing a critical role in increasing the adoption of CRRT among adult age group population
"North America represents one of the largest markets of Renal Replacement Therapy market."
For a better understanding of the market dynamics of the Renal Replacement Therapy market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of US$ XX million in 2020 owing to rising aging population. According to the United Nations, the geriatric population aged above 60 is expected to grow two-fold by 2050 and three-fold by 2100, an increase from 962 million in 2017 to 2.1 billion by 2050 and 3.1 billion by 2100
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts
- The report presents a quick review of overall industry performance at one glance
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
- The study comprehensively covers the market across different segments
- Deep dive regional level analysis of the industry
Customization Options:
The Renal Replacement Therapy Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
The Rise in the global incidence of AKI and increase in the demand for effective renal replacement therapy among ICU patients and initiatives undertaken by governments to increase the awareness about CRRT therapy along with the increase in the launch of advanced CRRT system area anticipated to fuel the Continuous Renal Replacement Therapy Market growth during the forecast period.
The growing worldwide incidence of AKI/AKF is, therefore, expected to increase the demand for CRRT. According to the International Society of Nephrology (INR), an estimated 13.3 million cases of AKI are registered annually worldwide. This is anticipated to boost the adoption of continuous renal replacement therapy at a rapid rate. With the rapid growth in the geriatric population globally, the prevalence of kidney-related diseases is expected to increase significantly. This, in turn, is expected to propel the growth of the CRRT market at a significant rate during the forecast period.
The new product launch and the strategic alliance sin the industry is creating an opportunity for the companies to grow. The companies are getting competitive edge by these alliances and launch. For instance: In 2020, Medtronic plc announced the launch of the Carpediem system, the first and only pediatric and neonatal acute dialysis system designed to treat patients weighing 2.5-10 kg (5.5-22 pounds) requiring renal replacement therapy.
Based on product, the market is segmented into Disposable, Machine, Dialysates, Renal Replacement fluid. Dialysate's segment is to capture largest market share during the forecast period. The largest market share of this segment is attributed to factors such growing demand for dialysates to remove undesired solutes and restoring the electrolytes and acid-base balance in the blood along with presence of well-established players with strong offerings in dialysates & replacement fluid.
Based on mode of patient, market is segmented into Adult, Pediatrics, Neonates. Adult segment dominated the continuous renal replacement therapy market in 2020 and witnessed the highest growth in forecast period.
Based on Modality, the market is segmented into SCUF, CVVH, CVVHD, CVVHDF. The CVVHDF is anticipated to witness the highest growth rate during the forecast period. The growing preference of CVVHDF modality among a nephrologist and critical care physician, and the advantages such as better clearance of medium-sized solutes as compared to hemodialysis (owing to the combination of hemofiltration with the continuous HD procedure), proper acid-base balance without additional intervention, and a significant reduction in CRRT-related phosphate depletion area likely to play strong role in supporting the growth of the segment in the coming years.
For a better understanding of the market penetration of the Continuous Renal Replacement Therapy market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of APAC), and Rest of World. North America constitutes a major market for disposable medical device sensor and generated revenue of USD XX billion in 2020 owing to the presence of well-established players in the region, emerging investment in healthcare R&D by players etc., However, the Asia Pacific region would grow at the highest CAGR during the forecast period.
Some of the major players operating in the Continuous Renal Replacement Therapy market are Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, NIKKISO CO., LTD., B. Braun Melsungen AG, Asahi Kasei Corporation, Toray Medical Co., Ltd. , Infomed SA, Medtronic plc, Nipro Corporation.
The global continuous renal replacement therapy market size is projected to reach USD XX billion by 2027 from USD XX billion in 2020, at a CAGR of XX % during the forecast period. Various factors such as rise in worldwide prevalence of AKI, Growing number of ICU patients with AKI and increasing incidence of sepsis, and growing clinical advantage of CRRT over intermittent blood purification are factors likely to boost the growth of the market.
Table of Contents
1 MARKET INTRODUCTION
1.1. Market Definitions
1.2. Objective of the Study
1.3. Limitation
1.4. Stake Holders
1.5. Currency Used in Report
1.6. Scope of the Global Continuous Renal Replacement Therapy Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1. Research Methodology for the Global Continuous Renal Replacement Therapy Market
2.1.1. Main Objective of the Global Continuous Renal Replacement Therapy Market
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 COVID-19 IMPACT
6 GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET REVENUE
7 MARKET INSIGHTS BY PRODUCT
7.1. Disposable
7.2. Machine
7.3. Dialysates
7.4. Renal Replacement fluids
8 `MARKET INSIGHTS BY MODALITY
8.1. SCUF
8.2. CVVH
8.3. CVVHD
8.4. CVVHDF
9 MARKET INSIGHTS BY PATIENT
9.1. Adult
9.2. Pediatrics
9.3. Neonates
10 MARKET INSIGHTS BY REGION
10.1. North America Continuous Renal Replacement Therapy Market
10.1.1. The U.S
10.1.2. Canada
10.1.3. Rest of North America
10.2. Europe Continuous Renal Replacement Therapy Market
10.2.1. Germany
10.2.2. France
10.2.3. U.K.
10.2.4. Spain
10.2.5. Italy
10.2.6. Rest of Europe
10.3. Asia Pacific Continuous Renal Replacement Therapy Market
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia
10.3.5. Rest of Asia Pacific
10.4. Rest of the World Continuous Renal Replacement Therapy Market
11 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET DYNAMICS
11.1. Market Drivers
11.2. Market Challenges
11.3. Impact Analysis
12 LEGAL & REGULATORY FRAMEWORK
13 DEMAND AND SUPPLY SIDE ANALYSIS
13.1. Demand Side Analysis
13.2. Supply Side Analysis
13.2.1. Top Product Launches
13.2.2. Top Business Partnerships
13.2.3. Top Merger & Acquisitions
14 VALUE CHAIN ANALYSIS
15 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET OPPORTUNITIES
16 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET TRENDS & INSIGHTS
17 COMPETITIVE SCENARIO
17.1. Porter's Five forces analysis
17.1.1. Bargaining power of Supplier
17.1.2. Bargaining power of Buyer
17.1.3. Industry Rivalry
17.1.4. Availability of Substitute
17.1.5. Threat of new Entrants
18 COMPANY PROFILED
18.1. Baxter International Inc.
18.1.1. Key Facts
18.1.2. Business Description
18.1.3. Key Product/Services Offerings
18.1.4. Growth Strategy
18.1.5. SWOT Analysis
18.1.6. Key Financials
18.1.6.1. Revenue Split
18.1.6.2. Financial Overview of Medline Industries, Inc.
18.1.7. Recent Developments
18.1.7.1. Product Launch
18.1.7.2. Partnerships
18.1.7.3. Business Expansion and Investments
18.1.7.4. Merger and Acquisition
18.2. Fresenius Medical Care AG & Co. KGaA
18.3. NIKKISO Co. Ltd.
18.4. B. Braun Melsungen AG
18.5. Medtronic plc
18.6. Toray Medical Co. Ltd.
18.7. Infomed SA
18.8. Nipro Corporation
19 DISCLAIMER
Baxter International Inc.
Fresenius Medical Care AG & Co. KGaA
NIKKISO CO.
LTD.
B. Braun Melsungen AG
Asahi Kasei Corporation
Toray Medical Co.
Ltd.
Infomed SA
Medtronic plc
Nipro Corporation